Author:
Schmalzing M.,Tony H.-P.,Knop S.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Kortüm M, Einsele H, Naumann R, Peest D, Liebisch P, Goldschmidt H (2010) Monoklonale Gammopathie unklarer Signifikanz. Leitlinie. Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen.
www.onkopedia.de
. Zugegriffen: 22.06.2017
2. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma. Br J Haematol 121:749–757
3. Mateos MV, Hernández MT, Giraldo P et al (2013) Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma. N Engl J Med 369(5):438–447
4. Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538–e548
5. Goldenberg GJ, Paraskevas F, Israels LG (1969) The association of rheumatoid arthritis with plasma cell neoplasm. Arthritis Rheum 12(6):569–579
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献